It is likely that we will have to update the #COVID19vaccines regularly to offer re-vaccination to vulnerable groups, as we do with the #Influenza vaccine. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603692179645415424
At the end of 2022, we have:
🔶7 #COVID19vaccines
🔶4 #AdaptedVaccines that target several variants of the virus
🔶vaccines for children from 6 months of age, particularly those with underlying conditions
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603692024573607939
EMA's regular press briefing on #PublicHealth emergencies https://n.respublicae.eu/i/broadcasts/1PlJQpdZXqXGE
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603691539594907648
‼️ EMA holds a regular press briefing on #PublicHealth emergencies. It will be broadcast live 🔴 today, 16 December 2022, from 11:00 to 11:30 CET.
#EMAPresser #COVID19 #RSV #Influenza
👉 https://www.ema.europa.eu/en/events/ema-regular-press-briefing-public-health-emergencies-0
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603685819432189955
What kind of services do the #EUeic and @EMA_News provide to researchers and #SMEs working in #pharmaceuticals and #medtech? 💊🩺
Find out at the EIC & EMA ℹ️ Info Day!
🗓️ 31 January 2023
💻 Online
Check out the agenda 👉 https://europa.eu/!jcNcFq
🐦🔗: https://n.respublicae.eu/EUeic/status/1603302936666316802
Have you missed the info session on the #EU4Health operating grants?
We've got you covered!
The recording and presentations are now available on #HaDEA website ⤵
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1603358934479298560
"With 17 million people being affected, #LongCOVID is a topic that should be high on all our agendas."
📺 Re-watch yesterday's 🇺🇸-🇪🇺-Long COVID conference, where we discussed research, treatment & our health systems’ response.
🔗https://health.ec.europa.eu/events/online-eu-us-conference-long-covid-2022-12-13_en
RT @EU_Health: As many as 1 in 8 people can experience symptoms that last much longer than expected, after recovering from COVID-19.
Join us online on 13…
🐦🔗: https://n.respublicae.eu/EU_Health/status/1603058896981360641
#LongCOVID's impact on health systems is huge.
To reduce the burden, our independent expert panel's recommendations include:
🔸scale up research on potential treatments & involve patients in research
🔸embed research at all levels of care, including rehabilitation
🐦🔗: https://n.respublicae.eu/EU_Health/status/1602654729191972866
RT @VaccinesToday: In September, we posted another expert interview - this time with the Chief Medical Officer from @EMA_News who explained how regulators assess #omicron #COVID19 boosters in time for winter
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602982839150346241
A number of European countries (IE, FR, NL, ES, SE and UK) indicate an increase seen during 2022, particularly since September, in the number of cases of invasive Group A Streptococcus (#iGAS) disease among children less than ten years of age.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1602350966313033731
All European countries should be vigilant for a similar rise in cases in children, considering, in particular, the increase in respiratory virus circulation that is now occurring across Europe.
More recommendations:
https://www.ecdc.europa.eu/en/news-events/increase-invasive-group-streptococcal-infections-among-children-europe-including
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1602350977574735878
#RSV infections at this time of the year are not unusual, but they are higher & earlier compared to pre-pandemic times.
The EU/EEA countries are also experiencing an early #influenza season and a possible resurgence of #COVID19 after weeks of decline in cases & hospitalisations.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1602398117663498241
RT @SandraGallina: Join us today at 14:00 to know more on long Covid:
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602649958318018560
#ECDC Rapid Risk Assessment.
Risk of severe pressure on healthcare systems due to #RSV, #flu and #COVID19 co-circulation.
Read more in our:
- press release here: https://bit.ly/RSVRRA2022
- #RRA report here: https://bit.ly/RSVPressR
and the thread below ⬇️⬇️⬇️
RT @ECDC_Outbreaks: #JustPublished!
Rapid Risk Assessment: Intensified circulation of respiratory syncytial virus (#RSV) and associated hospital burden in the EU/EEA.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1602397490698981376
📣"Science on the menu" #podcast🎙️| Episode 2⃣ out NOW!
🎇Are you looking forward to the holiday season to savour the finest traditional dishes?
🎧Our new episode is the perfect soundtrack to make sure the #food you prepare & eat is safe!
👉https://europa.eu/!dHXWNR
#OneHealth
🐦🔗: https://n.respublicae.eu/EFSA_EU/status/1602622258610163713
RT @EU_Health: 🔴TODAY from 14h CET
Join us & renowned experts to exchange knowledge on research, treatment & our health systems’ response to #LongCOVID
🇪🇺🇺🇸 | #HealthUnion
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602581141495681024
RT @EU_Health: 📢#EUFunding for #NGOs
Civil society organisations make an invaluable contribution to 🇪🇺 policy making & are crucial for a strong European #HealthUnion
The #EU4Health call for operating grants ends on 31 January 2023. Join our info session⬇⬇⬇
🗓13 Dec 2022
⏰11.00-13.30 CET
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602273936204566528
RT @EU_Health: Availability of & patient access to innovative technologies in the area of health is paramount.
Today, we have launched a call for applications to select members for a new Health Technology Assessment #HTA Stakeholder Network.
#HealthUnion #StrongerTogether
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602273889714855937
RT @ECDC_EU: This week @AfricaCDC & @_AfricanUnion organise the 2nd Int. Conference on Public Health in Africa.
#AfricaCDC Director - Dr Ouma & @ECDC_EU Director A. Ammon will open a side event on the importance of digitalization of #PublicHealth systems.
Follow #CPHIA2022 for more.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602273860698750976
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
➡️https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-12-15-december-2022_en.pdf
🐦🔗: https://n.respublicae.eu/EMA_News/status/1602253029020934145
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.